Indian Non-Medical Epilepsy Management Market Analysis


  • Type: Common Disease Area
  • Published : April 2021
  • Region: Asia
  • Country: India
  • Report ID : 1349

  • Format: PPT, PDF

Indian Non-Medical Epilepsy Management Market: Segmented By Diagnosis (Neurological Exam, Blood Test, Imaging), By Treatment (Medication, Surgery, Brain Stimulation) By End-Users (Hospitals, Clinics, Diagnostic Centers, Ambulatory Surgical Centers) – Growth, Trends and Forecasts (2019 – 2028)

SKU: 1349 Categories: ,

Report Overview

The Indian Non-Medical Epilepsy Management Market size stood at USD XX Billion in 2019 and is projected to reach USD XX Billion by 2028, exhibiting a CAGR of XX% during the forecast period

India carries an enormous burden of epilepsy. Around 10–12 million people with Non-Medical Epilepsy reside in India. A significant proportion of PWE do not receive appropriate treatment, leading to a large treatment gap (TG). Poor awareness of antiepileptic drugs (AEDs), cultural practices, social stigma surrounding epilepsy, lack of accessibility to healthcare, and a severe shortage of medical professionals trained in the management of Non-Medical Epilepsy are major contributors to the TG. The overall prevalence of Non-Medical Epilepsy in India is 5.59-10 per 1000. The age-adjusted prevalence ratio of active Non-Medical Epilepsy in Kerala is 4.7 per 1000 population. Rising support from governments and several companies can help in the fight against this highly contagious disease. There is also rising awareness levels about Non-Medical Epilepsy coupled with strategic alliances that are anticipated to stimulate the market growth.

Market Drivers

The increasing rate of Non-Medical Epilepsy prevalence in the geriatric community and the rise in accident-induced brain injury cases are major factors driving market growth. The high sensitivity risk of elderly Non-Medical Epilepsy is expected to fuel consumer demand. The rising awareness levels about Non-Medical Epilepsy coupled with strategic alliances are anticipated to stimulate the market growth. The awareness initiatives by Non-Medical Epilepsy networks have led to an increase in demand for better diagnosis and effective treatment of the disease. In addition, brain damage that can cause post-traumatic Non-Medical Epilepsy and post-traumatic seizures (PTS) can fuel demand in the Non-Medical Epilepsy industry. The demand for Non-Medical Epilepsy is also influenced by primary factors such as developing experimental medicines, the arrival of new drugs and the prevalence of neurological disorders such as meningitis and tumors. This rise is further fueled by an improvement in healthcare prices and an increase in disposable income.

1. Indian Non-Medical Epilepsy Management Market Overview………………
A. Market Size
2. Market Growth Drivers………………………………………………………………….
A. Growing R&D Investments towards COVID-19 Treatments
B. Increasing Rate of Non-Medical Epilepsy Prevalence in the Geriatric Community and the Rise in Accident-Induced Brain Injury Cases
3. Major Non-Medical Epilepsy Types………………………………………………
A. Idiopathic
B. Cryptogenic
C. Symptomatic
D. Others
4. Non-Medical Epilepsy Management Market Segmentation………………
A. Diagnosis
I. Neurological Exam
II. Blood Test
III. Imaging
IV. Others
B. Treatment
I. Medication
II. Surgery
III. Brain stimulation
IV. Others
C. End-Users
I. Hospitals
II. Clinics
III. Diagnostic Centers
IV. Ambulatory Surgical Centers
V. Others
5. Non-Medical Epilepsy Major Drugs Market Share……………………………
A. Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape…………………………………………………………………
A. Major Players
B. Products in Pipeline
7. Key Company Profiles…………………………………………………………………..
A. NATCO Company overview, Product & Services, Strategies & Financials
B. Sun Pharmaceuticals Company overview, Product & Services, Strategies & Financials
C. GlaxoSmithKline PLC Company, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape………………………………
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth……………………………………………………
A. New Trends and Development of Non-Medical Epilepsy Management Market
B. Future Opportunities
10. Conclusion

Market Segmentation

By Diagnosis:

On the basis of diagnosis, the market is segmented into neurological exam, blood test, imaging, and others. The imaging segment is sub-segmented into electroencephalogram, computerized tomography, magnetic resonance imaging, positron emission tomography, and others.

By Treatment:

On the basis of treatment, the market is segmented into medication, surgery, brain stimulation, and others. The medication segment is sub-segmented into acetazolamide, carbamazepine, clobazam, and others. The surgery segment is sub-segmented into hemispherectomy, corpus callosotomy, resection surgery, and others. The resection surgery segment is further segmented into temporal lobectomy, lesionectomy, and others. The brain stimulation segment is sub-segmented into deep brain stimulation, responsive neurostimulation, and others.

By End-Users:

Based on the end-users, the Non-Medical Epilepsy market is segmented into hospitals, clinics, diagnostic centers, ambulatory surgical centers, and others. The hospital segment is touted to dominate the market growth over the review period, followed by the clinics segment. Moreover, hospitals that encourage the procurement of medicine from hospital premises are likely to promote the market.

Major Players

The major players operating in the Indian Non-Medical Epilepsy market are Sanofi, Pfizer Inc., GW Pharmaceuticals, Sunovion Pharmaceuticals, Natco, Sun Pharmaceuticals, H. Lundbeck A/S, GlaxoSmithKline plc. Natco Pharma has launched for epilepsy treatment market ‘Brivaracetam’ in India. Sun Pharma about to launch range of Brivaracetam drug for Non-Medical Epilepsy treatment

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements